The $2.8 Billion Bomb Subsidy That Taxpayers Never Saw Coming
The Trump administration is using a little-noticed funding mechanism to give Israel $2.8 billion in bombs — money pulled directly from American taxpayers, not redirected defense budgets. It's a subsidy disguised as a sale.
The Hidden Mechanism Behind a $2.8 Billion Bomb Deal
Most arms sales from the United States to Israel follow a straightforward transaction: Israel writes a check, Lockheed Martin or another defense contractor delivers munitions, and the Pentagon records a sale. The money circulates back into the American economy.
This latest arrangement doesn’t work that way.
According to The Washington Post, the Trump administration is preparing a $2.8 billion transfer of bombs to Israel financed through Foreign Military Financing, a program that effectively hands American taxpayer dollars to a foreign government for the explicit purpose of buying weapons from American defense contractors. It is a circular subsidy — money pulled from U.S. Treasury accounts, handed to Israel, and spent back on U.S. munitions. The deal is framed as a sale. It functions as a purchase funded by the giver.
The distinction matters because it changes who pays, who profits, and what leverage disappears when the money never leaves American coffers in the first place.
What the Bombs Are — and What They Do
The munitions involved are among the most destructive in the U.S. arsenal. Forty thousand bombs weighing 2,000 pounds or more, many configured as bunker busters with penetrator warheads designed to create massive craters and send shrapnel hundreds of yards in every direction. The primary models are the MK-84 and BLU-117, unguided “dumb” bombs capable of being converted into smart munitions but devastating regardless.
Israel has already drawn criticism for using these weapons in densely populated areas across Gaza and Lebanon. Senator Mark Kelly stated that an MK-84 was used to kill Hezbollah Secretary-General Hassan Nasrallah in 2024. The weapon is significant enough that President Joe Biden prohibited its sale to Israel during the Gaza war — a restriction Trump reversed immediately upon returning to office.
Forty thousand of these bombs represents a scale of ordnance that goes well beyond replenishment. It is rearmament on an industrial scale, financed through a mechanism that obscures the cost from anyone not reading the fine print of defense appropriations.
The Politics of a Sale That Isn’t a Sale
Polling tells a clear story that the mechanics of this deal ignore. A 2024 survey found 52 percent of Americans believe the U.S. should stop sending weapons to Israel. A New York Times/Siena College poll released late last year showed a majority opposing additional military or economic aid. In June, a Quinnipiac poll found nearly half of U.S. voters think America is too supportive of Israel overall.
The administration has notified congressional committees of the planned transfer, as required. But past Trump-era arms deals have moved through expedited channels, raising questions about whether elected officials will have a meaningful window to intervene. A senior administration official told The Post that all foreign arms sales are “moving through the appropriate process” and declined to comment further on pending deals.
The vagueness of “appropriate process” is itself a signal. When the financing mechanism is obscure and the timeline compressed, scrutiny becomes the first casualty.
Why the Mechanism Matters More Than the Price Tag
The $2.8 billion figure sounds large. It is. But the real story is what this deal reveals about the architecture of U.S. weapons transfers to Israel.
Foreign Military Financing is not new. It has been used for decades to support allied defense purchases. What is notable here is the combination of scale, the specific munitions involved, and the fact that the money never leaves a closed loop — U.S. treasury to Israeli ministry of defense to U.S. defense contractor.
Under traditional sales, Israel raises its own funds, often through borrowing or reallocation from its budget. That creates natural pressure points. Lawmakers can scrutinize whether Israel can afford the purchase. Congress can debate whether the recipient should be spending that money on weapons at all. There is friction, however thin, built into the transaction.
FMF removes that friction entirely. The U.S. government becomes both the funder and the supplier, and the Israeli government becomes a conduit. There is no budgetary pain on the receiving end and no political cost on the American side beyond what congressional notification rules require.
This is the hidden ledger. The cost does not appear as a new appropriation. It appears as part of the baseline defense spending that authorizes FMF programs, spending that most voters never examine line by line.
The Strategic Implications
The United States has already expended enormous material during the conflict with Iran and provided Israel with critical interceptor missiles and other strategic resources. This latest transfer adds tens of thousands of large unguided bombs to an arsenal that has been actively used in populated combat zones.
The reversal of the MK-84 restriction is significant. Biden’s prohibition was one of the most concrete policy constraints placed on weapons transfers to Israel during the Gaza war. Its swift removal signals that the administrative posture toward Israeli military operations has shifted dramatically, regardless of what polling suggests about American public opinion.
There is also a longer-term implication for how the U.S. leverages military aid. When aid is structured as a direct subsidy rather than a sale, the traditional bargaining power embedded in arms transfers — the ability to attach conditions, to slow delivery, to make the recipient feel the cost — erodes. Israel receives weapons without paying for them through its own resources. The U.S. retains manufacturing contracts and defense jobs. Everyone in the machinery benefits. The public, which funds the program without seeing the transaction, does not.
What Comes Next
Congressional committees have been notified. Whether that notification translates into any substantive delay or revision remains unclear. The administration has indicated it is proceeding through established channels, though past precedent suggests those channels can move quickly when the political will exists.
The deal will likely face legal and procedural challenges from lawmakers concerned about transparency and the scope of the munitions involved. But the structural advantage of FMF — its opacity, its speed, its removal of financial friction — gives the administration considerable momentum.
For voters who oppose continued military aid to Israel, this arrangement is the hardest version to contest. There is no direct check to oppose. There is no bilateral agreement to scrutinize. There is only a budget line buried in defense spending and a press report that named the number. The politics of resistance require a visible target. This deal is designed to avoid one.
The $2.8 billion in bombs is not just a quantity of ordnance. It is a demonstration of how the U.S. military-aid system can be reconfigured to deliver maximum capability with minimum political visibility.